Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Chemical Society Reviews|February 9, 2016
Harnessing the bone-seeking ability of Ca(II)-like metal ions in the treatment of metastatic cancer and resorption disordersD M Weekes, C OrvigClinical Chemistry|April 1, 1992
Complexation of iron with the orally active decorporation drug L1 (3-hydroxy-1,2-dimethyl-4-pyridinone)M A Kline, C OrvigInorganic Chemistry|July 10, 2001
Lanthanide chemistry with (bis[[bis(carboxymethyl)amino]methyl]phosphinate: what does an extra phosphinate group do to EDTA?L Xu, S J Rettig, C OrvigNeurotoxicology and Teratology|June 25, 1998
Active oxygen species formation in synaptosomes exposed to an aluminum chelatorS C Bondy, H Tseng, C OrvigToxicology|April 12, 1995
Evidence for energy-dependent transport of aluminum out of brain extracellular fluidD D Allen, C Orvig, R A YokelCanadian Journal of Physiology and Pharmacology|March 1, 1993
Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)V G Yuen, C Orvig, J H McNeillCanadian Journal of Physiology and Pharmacology|January 1, 1995
Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administrationV G Yuen, C Orvig, J H McNeillToxicology|September 6, 1994
Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapyD D Allen, C Orvig, R A YokelNeurotoxicology|January 1, 1994
Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous systemD D Allen, C Orvig, R A YokelThe American Journal of Physiology|January 1, 1997
Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic ratsV G Yuen, C Orvig, J H McNeillPageof 7